GLP-1 receptor agonists and skeletal muscle: The risk of sarcopenic obesity and the role of resistance training. A narrative review

作者
Roksana Milaniuk,Aleksandra Drzewiecka,Szymon Daniszewski,Izabela Czerny,Beata Surówka,Wioleta Pluta,Krzysztof Talarowski,Piotr Tylec,Arkadiusz Ściubak,Jakub Bryl,Aleksandra Pacek
出处
期刊:Quality in Sport [Kazimierz Wielki University in Bydgoszcz]
卷期号:69: 74557-74557
标识
DOI:10.12775/qs.2026.69.74557
摘要

Background. GLP-1 receptor agonists (GLP-1 RAs) and incretin-based co-agonists have transformed the management of obesity and type 2 diabetes, producing weight loss approaching that of bariatric surgery. Attention has shifted from the quantity of weight lost to its quality - the proportion of fat versus skeletal muscle (lean) mass removed. A meaningful fraction of GLP-1 RA-induced loss is lean tissue, raising concern that these agents may unmask or aggravate sarcopenic obesity Aim. To synthesise evidence on GLP-1 RAs’ effect on skeletal muscle and body composition, characterise the risk of sarcopenic obesity, and appraise resistance training, nutritional and pharmacological countermeasures. Material and methods. A review used PubMed and Google Scholar. RCTs, observational studies, reviews, meta-analyses and relevant preclinical research published in English between 2018 and 2026 were analysed. Results. Absolute lean-mass reductions represent ~20-40% of total weight lost. Contemporary imaging suggests these changes are largely adaptive - commensurate with weight loss - rather than pathological. Principal drivers are reduced energy and protein intake from appetite suppression, catabolic drive, inactivity and anabolic resistance, not direct toxicity. Resistance training with adequate protein (~1.2-1.6 g/kg/day) is the best-established preservation strategy, and activin/myostatin blockers (e.g. bimagrumab) reduce lean-mass loss in early trials. A meta-analysis of tirzepatide trials reported improved physical function versus placebo. Conclusions. Skeletal-muscle loss is a real, quantifiable consequence of GLP-1 RA therapy, though heterogeneous and often adaptive. Older adults, patients with type 2 diabetes, peri- and postmenopausal women, and those with low baseline muscle mass are at greatest risk. Structured resistance training with optimised protein should accompany therapy in at-risk patients; muscle-preserving pharmacotherapy is a rapidly evolving frontier.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
HAPPY完成签到,获得积分10
3秒前
桐桐的应助被Vincent采纳,获得10
4秒前
keleboys完成签到 ,获得积分10
6秒前
HMZ完成签到 ,获得积分10
8秒前
9秒前
HU完成签到 ,获得积分10
11秒前
12秒前
16秒前
小尾巴完成签到 ,获得积分10
19秒前
章鱼行者完成签到,获得积分10
19秒前
鲁文杰发布了新的文献求助10
20秒前
Maestro_S的应助被Vincent采纳,获得10
22秒前
23秒前
万能图书馆的应助被Vincent采纳,获得10
29秒前
29秒前
水静完成签到,获得积分10
30秒前
川川完成签到 ,获得积分10
34秒前
35秒前
科研通AI6.4的应助被Vincent采纳,获得10
35秒前
36秒前
标致访旋完成签到,获得积分10
37秒前
烂漫墨镜完成签到 ,获得积分10
40秒前
20230054发布了新的文献求助10
42秒前
42秒前
隐形曼青的应助被Vincent采纳,获得10
44秒前
鲁文杰完成签到,获得积分10
47秒前
47秒前
整齐百褶裙完成签到 ,获得积分10
52秒前
Changhiwi完成签到 ,获得积分10
53秒前
李健的小迷弟的应助被Vincent采纳,获得10
54秒前
54秒前
彳系禾完成签到 ,获得积分10
55秒前
Jzhaoc580完成签到 ,获得积分10
57秒前
冷艳凡灵完成签到,获得积分10
1分钟前
花果茶百道完成签到 ,获得积分10
1分钟前
1分钟前
一定长完成签到,获得积分10
1分钟前
华仔的应助被Vincent采纳,获得10
1分钟前
平静完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190366
求助须知:如何正确求助?哪些是违规求助? 9577437
关于积分的说明 21852521
捐赠科研通 7788988
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560144
邀请新用户注册赠送积分活动 2482995